Mutations in proline 82 of p53 impair its activation by Pin1 and Chk2 in response to DNA damage

Molecular and Cellular Biology

Volumn 25, Issue 13, 2005, Pages 5380-5388

  Berger, Michael ^a   Stahl, Nathalie ^a   Del Sal, Giannino ^b,c   Haupt, Ygal ^a  

^a HEBREW UNIVERSITY   (Israel)

^b Laboratorio Nazionale CIB   (Italy)

^c Dipartimento di Biochimica Biofisica Chimica Delle Macromolecole   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHECKPOINT KINASE 2; DNA; PEPTIDYLPROLYL ISOMERASE PIN1; POLYPROLINE; PROLINE; PROLINE DERIVATIVE; PROTEIN MDM2; PROTEIN P53; SERINE; THREONINE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CIS TRANS ISOMERISM; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DNA DAMAGE; GENE MUTATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION;

ANIMALS; CELL LINE; CELL LINE, TUMOR; DNA DAMAGE; EMBRYO; FIBROBLASTS; GENE DELETION; HUMANS; MICE; OSTEOSARCOMA; PEPTIDYLPROLYL ISOMERASE; PHOSPHORYLATION; PROLINE; PROTEIN BINDING; PROTEIN-SERINE-THREONINE KINASES; SERINE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 20744432450     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.25.13.5380-5388.2005     Document Type: Article

References (31)

1. Baptiste, N., P. Friedlander, X. Chen, and C. Prives. 2002. The proline-rich domain of p53 is required for cooperation with anti-neoplastic agents to promote apoptosis of tumor cells. Oncogene 21:9-21.
2. Bartek, J., and J. Lukas. 2003. Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell 3:421-429.
3. Berger, M., R. Vogt Sionov, A. J. Levine, and Y. Haupt. 2001. A role for the polyproline domain of p53 in its regulation by Mdm2. J. Biol. Chem. 276:3785-3790.
4. 1 by stabilizing p53. Genes Dev. 14:278-288.
5. Chehab, N. H., A. Malikzay, E. S. Stavridi, and T. D. Halazonetis. 1999. Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage. Proc. Natl. Acad. Sci. USA 96:13777-13782.
6. Chipuk, J. E., T. Kuwana, L. Bouchier-Hayes, N. M. Droin, D. D. Newmeyer, M. Schuler, and D. R. Green. 2004. Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 303:1010-1014.
7. Craig, A., M. Scott, L. Burch, G. Smith, K. Ball, and T. Hupp. 2003. Allosteric effects mediate CHK2 phosphorylation of the p53 transactivation domain. EMBO Rep. 4:787-792.
8. Crenshaw, D. G., J. Yang, A. R. Means, and S. Kornbluth. 1998. The mitotic peptidyl-prolyl isomerase, Pin1, interacts with Cdc25 and Plx1. EMBO J. 17:1315-1327.
9. Edwards, S. J., L. Hananeia, M. R. Eccles, Y. F. Zhang, and A. W. Braithwaite. 2003. The proline-rich region of mouse p53 influences transactivation and apoptosis but is largely dispensable for these functions. Oncogene 22:4517-4523.
10. Falck, J., C. Lukas, M. Protopopova, J. Lukas, G. Selivanova, and J. Bartek. 2001. Functional impact of concomitant versus alternative defects in the Chk2-p53 tumour suppressor pathway. Oncogene 20:5503-5510.
11. Haupt, Y., Y. Barak, and M. Oren. 1996. Cell type-specific inhibition of p53-mediated apoptosis by mdm2. EMBO J. 15:1596-1606.
12. Hayon, I. L., and Y. Haupt. 2002. p53: an internal investigation. Cell Cycle 1:111-116.
13. Hirao, A., Y. Y. Kong, S. Matsuoka, A. Wakeham, J. Ruland, H. Yoshida, D. Liu, S. J. Elledge, and T. W. Mak. 2000. DNA damage-induced activation of p53 by the checkpoint kinase Chk2. Science 287:1824-1827.
14. Iwakuma, T., and G. Lozano. 2003. MDM2, an introduction. Mol. Cancer Res. 1:993-1000.
15. Joseph, J. D., E. S. Yeh, K. I. Swenson, A. R. Means, and Winkler. 2003. The peptidyl-prolyl isomerase Pin1. Prog. Cell Cycle Res. 5:477-487.
16. Lu, K. P. 2003. Prolyl isomerase Pin1 as a molecular target for cancer diagnostics and therapeutics. Cancer Cell 4:175-180.
17. Ryo, A., M. Nakamura, G. Wulf, Y. C. Liou, and K. P. Lu. 2001. Pin1 regulates turnover and subcellular localization of beta-catenin by inhibiting its interaction with APC. Nat. Cell Biol. 3:793-801.
18. Sakamuro, D., P. Sabbatini, E. White, and G. C. Prendergast. 1997. The polyproline region of p53 is required to activate apoptosis but not growth arrest. Oncogene 15:887-898.
19. Shieh, S. Y., J. Ahn, K. Tamai, Y. Taya, and C. Prives. 2000. The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites. Genes Dev. 14:289-300.
20. Sionov, R. V., and Y. Haupt. 1999. The cellular response to p53: the decision between life and death. Oncogene 18:6145-6157.
21. Stukenberg, P. T., and M. W. Kirschner. 2001. Pin1 acts catalytically to promote a conformational change in Cdc25. Mol. Cell 7:1071-1083.
22. Sun, X. F., O. Johannsson, S. Hakansson, G. Sellberg, B. Nordenskjold, H. Olsson, and A. Borg. 1996. A novel p53 germline alteration identified in a late onset breast cancer kindred. Oncogene 13:407-411.
23. Taylor, J. A., Y. Li, M. He, T. Mason, C. Mettlin, W. J. Vogler, S. Maygarden, and E. Liu. 1996. p53 mutations in bladder tumors from arylamine-exposed workers. Cancer Res. 56:294-298.
24. Unger, T., T. Juven-Gershon, E. Moallem, M. Berger, R. Vogt Sionov, G. Lozano, M. Oren, and Y. Haupt. 1999. Critical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2. EMBO J. 18:1805-1814.
25. Venot, C., M. Maratrat, C. Dureuil, E. Conseiller, L. Bracco, and L. Debussche. 1998. The requirement for the p53 proline-rich functional domain for mediation of apoptosis is correlated with specific PIG3 gene transactivation and with transcriptional repression. EMBO J. 17:4668-4679.
26. Vogt Sionov, R., L. I. Hayon, and Y. Haupt. 2001. The regulation of p53 growth suppression, p. 106-125. In M. V. Blagosklonny (ed.), Cell cycle checkpoints and cancer. Landes Bioscience, Georgetown, Tex.
27. Walker, K. K., and A. J. Levine. 1996. Identification of a novel p53 functional domain that is necessary for efficient growth suppression. Proc. Natl. Acad. Sci. USA 93:15335-15340.
28. Wulf, G. M., Y. C. Liou, A. Ryo, S. W. Lee, and K. P. Lu. 2002. Role of Pin1 in the regulation of p53 stability and p21 transactivation, and cell cycle checkpoints in response to DNA damage. J. Biol. Chem. 277:47976-47979.
29. Zacchi, P., M. Gostissa, T. Uchida, C. Salvagno, F. Avolio, S. Volinia, Z. Ronai, G. Blandino, C. Schneider, and G. Del Sal. 2002. The prolyl isomerase Pin1 reveals a mechanism to control p53 functions after genotoxic insults. Nature 419:853-857.
30. Zheng, H., H. You, X. Z. Zhou, S. A. Murray, T. Uchida, G. Wulf, L. Gu, X. Tang, K. P. Lu, and Z. X. Xiao. 2002. The prolyl isomerase Pin1 is a regulator of p53 in genotoxic response. Nature 419:849-853.
31. Zhu, J., J. Jiang, W. Zhou, K. Zhu, and X. Chen. 1999. Differential regulation of cellular target genes by p53 devoid of the PXXP motifs with impaired apoptotic activity. Oncogene 18:2149-2155.